title: SAPHO syndrome treatment with intravenous pamidronate. Retrospective study of 22 patients.
authors.affiliation: Service de rhumatologie, CHRU de Besançon, Besançon, France.
authors.forename: Emilie
authors.initials: E
authors.lastname: Delattre
authors.affiliation: Service de rhumatologie, CHRU de Besançon, Besançon, France.
authors.forename: Xavier
authors.initials: X
authors.lastname: Guillot
authors.affiliation: Service de rhumatologie, CHRU de Besançon, Besançon, France.
authors.forename: Marie
authors.initials: M
authors.lastname: Godfrin-Valnet
authors.affiliation: Service de rhumatologie, CHRU de Besançon, Besançon, France.
authors.forename: Clément
authors.initials: C
authors.lastname: Prati
authors.affiliation: Service de rhumatologie, CHRU de Besançon, Besançon, France. Electronic address: dwendling@chu-besancon.fr.
authors.forename: Daniel
authors.initials: D
authors.lastname: Wendling
mesh_terms: D020083:Acquired Hyperostosis Syndrome / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D004164:Diphosphonates / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D000077268:Pamidronate; D012189:Retrospective Studies
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D000077268:Pamidronate
keywords: Bisphosphonates; Pamidronate; SAPHO; Treatment